News
News

The latest updates from AFAR.

Grantee in the News: New Research from Leora Horwitz Published in JAMA

Jan 27
2016

Grantee in the News: New Research from Leora Horwitz Published in JAMA

The January 19, 2016 issue of JAMA included new research on physician likelihood of dying in a hospital from 2010 Beeson Scholar, Leora Horwitz, MD.  Dr. Horwitz’s team used US Census Bureau surveys matched to the National Death Index to compare the location of death for physicians with that of other health professionals, non–health care professionals with similar education levels, and the general population aged 30 to 98 years who died between 1979 and 2011. A segment of the study can be viewed here. Leora Horwitz, MD, is an associate professor in the Departments of Population Health and Medicine at New York…


View MoreREAD MORE


Industry News: NY Times highlights Geriatrician Shortage

Jan 26
2016

Industry News: NY Times highlights Geriatrician Shortage

On January 25, 2016, The New York Times Science section highlighted the shortage of doctors trained in the specific care needs of older adults, featuring Rosanne Leipzig, MD, PhD, an site Program Officer of the Centers of Excellence, program, which AFAR has managed. “Geriatrics is one of the few medical specialties in the United States that is contracting even as the need increases, ranking at the bottom of the list of specialties that internal medicine residents choose to pursue,” the pieces notes. There are about 7,000 geriatricians in practice today in the US, to meet the demand, medical schools would…


View MoreREAD MORE


Board Member in the News: Scientific Director Steven Austad Op-Ed on TAME Trial for CNN.com

Jan 15
2016

Board Member in the News: Scientific Director Steven Austad Op-Ed on TAME Trial for CNN.com

On December 13, 2015, AFAR’s Scientific Director, Steven Austad, PhD, contributed an OpEd to CNN.com entitled, “Could one pill help you live longer?”  In this piece, Dr. Austad explains that with the potential to cripple health and economic systems, aging represents one of the biggest threats facing the world today.  This OpEd also lays the answer to common questions on the TAME study including:  Wouldn't such a study take decades and be cripplingly expensive? Why go to the time and expense of doing a clinical trial? What if it doesn't work?. Read…


View MoreREAD MORE


Board Member in the News: TAME Trial Named One of the Seven Top Innovations of 2015

Jan 06
2016

Board Member in the News: TAME Trial Named One of the Seven Top Innovations of 2015

Congratulations to Deputy Scientific Director, Nir Barzilai, MD, and the entire TAME team on being including as one the “7 of the biggest innovations that made headlines in 2015” by The Washington Post. The article described how aging research is making strides toward showing that the decline in health that comes with aging isn't as inevitable as once thought. The piece also positions how after receiving positive feedback from the FDA, Barzilai and fellow investigators are working to develop a study design that can demonstrate how warding off the effects of aging can be as viable a way of…


View MoreREAD MORE




BACK TO TOPBACK TO TOP